Longeveron: WHO Approves “Laromestrocel” for Lomecel-B™ Stem Cell Therapy
Longeveron Inc. announced that the World Health Organization (WHO) has approved the International Non-proprietary Name (INN) “laromestrocel” for their cellular therapy Lomecel-B™. Lomecel-B™ is being evaluated as a treatment for Alzheimer’s disease and hypoplastic left heart syndrome (HLHS). It is a proprietary product made from medicinal signaling cells and has received FDA designations such as […]
Genetically Engineered Stem Cells Fight Gastroesophageal Cancer
Dr. Saar Gill of the University of Pennsylvania received a $450,000 grant from the DeGregorio Family Foundation to continue research on genetically engineered stem cells to combat gastroesophageal cancer. This builds upon previous work using Chimeric Antigen Receptor (CAR) macrophages to target and destroy cancer cells within solid tumors. The ultimate goal is to develop a long-lasting supply of cancer-fighting cells. […]
GATC Health’s Stem Cell Therapy for Diabetes
GATC Health Corp. announced a groundbreaking stem cell therapy for diabetes, detailed in a recent publication in the American Journal of Biomedical Science & Research. This autologous therapy uses a patient’s own stem cells to potentially treat both Type 1 and Type 2 diabetes, offering improved blood sugar control and reduced medication dependence. The process is […]
How Stem Cell Technology is Transforming IVF
Ever wondered if there’s a way to make IVF less of a rollercoaster? Or if science could give fertility a second chance? Well, stem cell technology is stepping up to the plate, and it’s changing the game for IVF and infertility treatment. Let’s break it down—no jargon, no fluff—just the real deal on how stem cells are rewriting the […]
Reversing Aging: Professor Thomas Rando Reveals Stem Cell Secrets & Lifestyle Hacks
Unlocking the secrets of youth and regeneration, Professor Thomas Rando delves into groundbreaking insights on stem cells, aging, and the profound impacts of lifestyle interventions. This enlightening talk unveils the regenerative capabilities of muscle and other tissues, the role of epigenetics, and the remarkable rejuvenation effects of exercise and fasting. Rando’s research highlights the transformative […]
NYSCF and Janssen Partner on Neurodegenerative Disease Drug Discovery
The New York Stem Cell Foundation Research Institute (NYSCF) and Janssen Research & Development, a Johnson & Johnson company, have partnered to accelerate the development of precision medicines for neurodegenerative diseases. NYSCF’s AI-powered platform, using automated stem cell systems, will be leveraged to identify new drug targets and therapies. This collaboration combines NYSCF’s expertise in stem cell […]
Dispelling the Myths of IV Stem Cell Therapy with Dr. Joy Kong
In her latest video, Dr. Joy Kong tackles a persistent myth in stem cell therapy: the idea that stem cells delivered through IV get trapped in the lungs. This outdated notion has confused patients and misled some healthcare providers for far too long. Dr. Kong dives into the science, sharing groundbreaking research and real-world insights […]
BioCentriq Expands Cell Therapy Manufacturing
This exciting news in the cell therapy sector could revolutionize how quickly life-changing therapies reach patients. BioCentriq, a leading cell therapy contract development and manufacturing organization (CDMO), is set to expand its operations and establish a cutting-edge cell therapy manufacturing facility in Princeton, New Jersey. This facility will become BioCentriq’s new headquarters, marking a significant […]
The Healing Power of Stem Cells: Dr. Joy Kong Explains How Quickly Results Can Be Seen
In the enlightening video below, Dr. Joy Kong delves into the fascinating science behind stem cell therapy and answers one of the most common questions: “How soon can I see results?” With her characteristic clarity and passion for regenerative medicine, Dr. Kong breaks down the multi-phase process of healing facilitated by stem cells, including their […]
FDA Grants Breakthrough Therapy Designation to Seres’ SER-155
Seres Therapeutics announced that the FDA granted Breakthrough Therapy designation to SER-155, their lead investigational drug, for reducing bloodstream infections in adults undergoing stem cell transplants. This designation is based on positive Phase 1b clinical trial data showing a significant reduction in infections compared to a placebo. A meeting with the FDA to discuss the […]